Heron Therapeutics, Inc. (HRTX)
0.3028
+0.01
(+2.23%)
USD |
NASDAQ |
Oct 23, 16:00
0.3003
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Market Cap : 57.37M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 57.37M |
| October 22, 2026 | 56.12M |
| October 21, 2026 | 64.19M |
| October 20, 2026 | 67.16M |
| October 19, 2026 | 68.38M |
| October 16, 2026 | 68.39M |
| October 15, 2026 | 71.33M |
| October 14, 2026 | 68.58M |
| October 13, 2026 | 74.00M |
| October 12, 2026 | 78.74M |
| October 09, 2026 | 76.94M |
| October 08, 2026 | 67.86M |
| October 07, 2026 | 72.81M |
| October 06, 2026 | 62.84M |
| October 05, 2026 | 70.10M |
| October 02, 2026 | 65.86M |
| October 01, 2026 | 67.43M |
| September 30, 2026 | 59.40M |
| September 29, 2026 | 57.97M |
| September 28, 2026 | 55.28M |
| September 25, 2026 | 55.74M |
| September 24, 2026 | 54.94M |
| September 23, 2026 | 55.13M |
| September 22, 2026 | 56.65M |
| September 21, 2026 | 51.15M |
| Date | Value |
|---|---|
| September 18, 2026 | 58.68M |
| September 17, 2026 | 59.81M |
| September 16, 2026 | 60.21M |
| September 15, 2026 | 59.49M |
| September 14, 2026 | 59.74M |
| September 11, 2026 | 59.77M |
| September 10, 2026 | 61.06M |
| September 09, 2026 | 63.09M |
| September 08, 2026 | 66.31M |
| September 04, 2026 | 65.16M |
| September 03, 2026 | 62.52M |
| September 02, 2026 | 59.28M |
| September 01, 2026 | 59.68M |
| August 31, 2026 | 60.25M |
| August 28, 2026 | 61.88M |
| August 27, 2026 | 62.92M |
| August 26, 2026 | 59.15M |
| August 25, 2026 | 61.21M |
| August 24, 2026 | 61.16M |
| August 21, 2026 | 60.29M |
| August 20, 2026 | 58.54M |
| August 19, 2026 | 59.66M |
| August 18, 2026 | 57.01M |
| August 17, 2026 | 60.63M |
| August 14, 2026 | 63.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Tonix Pharmaceuticals Holding Corp. | 86.82M |
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
Market Cap Related Metrics
| PS Ratio | 0.3697 |
| PEG Ratio | -0.0009 |
| Price to Book Value | 9.793 |
| Price | 0.3028 |
| Earnings Yield | -62.75% |
| PEGY Ratio | -0.0009 |